Formulation and in Vitro Evaluation of Theophylline-Eudragit® Sustained-Release Tablets

Revista Brasileira de Ciências Farmacêuticas
doi 10.1590/s1516-93322005000300011
Full Text
Abstract

Available in full text

Date
Authors
Publisher

FapUNIFESP (SciELO)

Related search

Eudragit NE30D Based Metformin/Gliclazide Extended Release Tablets: Formulation, Characterisation and in Vitro Release Studies

Chemical and Pharmaceutical Bulletin
MedicineDrug DiscoveryChemistry
2002English

Solid Stability Testing of Ibuprofen - Eudragit Respm Sustained Release Tablets

Bulletin of Pharmaceutical Sciences
PharmacologyPharmaceutical Science
1993English

Formulation and Evaluation of Metformin Hydrochloride Sustained-Release Oral Matrix Tablets

Asian Journal of Pharmaceutical and Clinical Research
PharmacologyPharmaceutical Science
2018English

Design, Formulation and Evaluation of Sustained Release Bilayer Tablets of Ciprofloxacin Hydrochloride

Journal of Drug Delivery and Therapeutics
2019English

Preparation and Evaluation of Sustained Release Carbamazepine Matrix Tablets Using Eudragit RS 100 and Tragacanth

Bulletin of Pharmaceutical Sciences
PharmacologyPharmaceutical Science
2001English

The Development of Eudragit® NM-Based Controlled-Release Matrix Tablets

Medicina
Medicine
2012English

Formulation and Evaluation of Finasteride Sustained-Release Matrix Tablets Using Different Rate Controlling Polymers

Universal Journal of Pharmaceutical Research
2016English

Formulation and Evaluation of Sustained Release Matrix Tablets of Levosulpiride by Using Natural Polymer

Asian Journal of Pharmaceutical and Clinical Research
PharmacologyPharmaceutical Science
2017English

Evaluation of Zein Tablets for Sustained-Release Dosage From in Vitro and in Vivo.

Drug Delivery System
Pharmaceutical Science
1997English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy